Skip to main content

Scientists Discover Way to Send Information into Black Holes Without Using Energy

This Powder Could Save Brain Injury Patients And It Fits in an Ambulance

Every year, millions of people suffer from traumatic brain injuries (TBI)—often caused by road accidents, falls, or violence. These injuries are especially dangerous because they don’t just cause immediate damage; they can trigger life-threatening complications days later. Now, scientists from University of California, San Francisco have developed a promising new solution: a freeze-dried blood product that could one day be stored in ambulances and remote clinics, ready to save lives when every second counts.

The Hidden Danger of Brain Injuries

When someone experiences a traumatic brain injury, the initial impact can cause bleeding in the brain. But the real danger often comes later. Over time, the brain can begin to swell due to leaking blood vessels—a condition known as cerebral edema. This swelling increases pressure inside the skull, which can damage brain tissue and even lead to death.

Currently, doctors have very limited tools to treat this condition. In severe cases, surgeons may need to remove part of the skull to relieve pressure. While this can save lives, it is highly invasive and not always effective. There is still no widely available drug that directly targets and reduces brain swelling.

This gap in treatment options has made TBI one of the leading causes of death in people under the age of 44. Clearly, a better solution is urgently needed.

Introducing “Thrombosomes”

The new product, known as thrombosomes, could be a game changer. Originally developed for battlefield medicine, thrombosomes are derived from platelets—tiny components in blood that help with clotting. What makes them unique is that they are freeze-dried using a natural sugar called trehalose, which helps preserve their beneficial properties.

Unlike fresh platelets, which must be refrigerated and only last about seven days, thrombosomes can be stored for up to five years. This long shelf life makes them ideal for use in emergency situations, especially in remote areas where access to fresh blood products is limited.

How They Work

Platelets are best known for their role in stopping bleeding, but scientists have discovered that they do much more. They carry a variety of powerful molecules that help repair damaged tissues and stabilize blood vessels.

In this study, published in the Blood Journal, researchers found that thrombosomes contain high levels of a specific protein that activates receptors on blood vessel cells. This interaction helps strengthen the vessel walls, making them less likely to leak.

By reinforcing these vessels, thrombosomes may prevent both bleeding and the dangerous swelling that follows a brain injury.

Promising Results in Early Tests

The research team tested thrombosomes in multiple ways. First, they used petri dishes and advanced 3D models that mimic human blood vessels. In these controlled environments, the product helped cells resist damage and maintain their structure.

Next, the scientists tested the treatment in mice with traumatic brain injuries. The results were encouraging. Mice that received thrombosomes—whether one hour or even a full day after injury—showed:

  • Reduced brain bleeding

  • Stronger, less leaky blood vessels

  • Lower levels of inflammation

Inflammation is a key factor in brain swelling, so reducing it is a major step toward preventing long-term damage.

Why This Matters

One of the most exciting aspects of this discovery is its potential real-world impact. Because thrombosomes are stable and easy to store, they could be kept in ambulances, military settings, and rural hospitals. This means patients could receive treatment much sooner—possibly even before reaching a major medical center.

Early intervention is critical in brain injuries. The sooner doctors can stop bleeding and prevent swelling, the better the chances of survival and recovery.

Beyond Clotting: A Powerful Cocktail

According to the researchers, thrombosomes may be more effective than regular platelets because they concentrate a range of beneficial molecules. Instead of just helping blood clot, they appear to deliver a “cocktail” of healing factors that support blood vessel repair and reduce inflammation.

This discovery opens the door to a new way of thinking about blood-based therapies. Rather than using whole blood components, scientists can refine and enhance specific elements to target complex conditions like TBI.

Moving Toward Human Use

While the results so far are based on animal studies, there is good news for future development. Thrombosomes are already in Phase II clinical trials for treating bleeding disorders. This means they have been tested for safety in humans, which could speed up the process of testing them specifically for brain injuries.

If future trials confirm their effectiveness in people, thrombosomes could become the first widely available drug to directly treat the underlying causes of brain swelling after injury.

Challenges Ahead

Despite the excitement, there are still challenges to overcome. Treatments that work in mice do not always produce the same results in humans. Researchers will need to carefully study how thrombosomes behave in the human brain and determine the correct dosage and timing.

There are also regulatory hurdles to clear before the product can be approved for widespread use. However, the fact that it is already being tested in humans for other conditions is a strong advantage.

A New Era in Emergency Medicine?

The development of thrombosomes represents a significant step forward in the search for effective TBI treatments. It combines advances in biology, medicine, and technology to create a solution that is both practical and potentially life-saving.

Imagine a future where paramedics can carry a small vial of freeze-dried platelets that can be quickly rehydrated and administered at the scene of an accident. Such a tool could dramatically improve survival rates and reduce long-term disability for millions of patients.

Conclusion

Traumatic brain injuries have long been one of the most difficult medical challenges to treat. With limited options and high risks, patients and doctors have often had to rely on invasive procedures and supportive care.

Thrombosomes offer a new hope. By stabilizing blood vessels, reducing bleeding, and preventing inflammation, this innovative product could transform how we treat brain injuries—bringing fast, effective care directly to those who need it most.

While more research is needed, the early results are promising. If successful in human trials, this freeze-dried blood product could mark the beginning of a new era in emergency medicine—one where lifesaving treatment is not only more effective but also more accessible than ever before.

Reference: Alpa Trivedi et al, A Dried Platelet-Derived Biologic for Blood-Brain Barrier Repair and Hemorrhage Control Following TBI in Mice, Blood Journal (2026). DOI: 10.1182/blood.2025031826

Comments

Popular

Scientists Discover Way to Send Information into Black Holes Without Using Energy

For years, scientists believed that adding even one qubit (a unit of quantum information) to a black hole needed energy. This was based on the idea that a black hole’s entropy must increase with more information, which means it must gain energy. But a new study by Jonah Kudler-Flam and Geoff Penington changes that thinking. They found that quantum information can be teleported into a black hole without adding energy or increasing entropy . This works through a process called black hole decoherence , where “soft” radiation — very low-energy signals — carry information into the black hole. In their method, the qubit enters the black hole while a new pair of entangled particles (like Hawking radiation) is created. This keeps the total information balanced, so there's no violation of the laws of physics. The energy cost only shows up when information is erased from the outside — these are called zerobits . According to Landauer’s principle, erasing information always needs energy. But ...

Black Holes That Never Dies

Black holes are powerful objects in space with gravity so strong that nothing can escape them. In the 1970s, Stephen Hawking showed that black holes can slowly lose energy by giving off tiny particles. This process is called Hawking radiation . Over time, the black hole gets smaller and hotter, and in the end, it disappears completely. But new research by Menezes and his team shows something different. Using a theory called Loop Quantum Gravity (LQG) , they studied black holes with quantum corrections. In their model, the black hole does not vanish completely. Instead, it stops shrinking when it reaches a very small size. This leftover is called a black hole remnant . They also studied something called grey-body factors , which affect how much energy escapes from a black hole. Their findings show that the black hole cools down and stops losing mass once it reaches a minimum mass . This new model removes the idea of a “singularity” at the center of the black hole and gives us a better ...

How Planetary Movements Might Explain Sunspot Cycles and Solar Phenomena

Sunspots, dark patches on the Sun's surface, follow a cycle of increasing and decreasing activity every 11 years. For years, scientists have relied on the dynamo model to explain this cycle. According to this model, the Sun's magnetic field is generated by the movement of plasma and the Sun's rotation. However, this model does not fully explain why the sunspot cycle is sometimes unpredictable. Lauri Jetsu, a researcher, has proposed a new approach. Jetsu’s analysis, using a method called the Discrete Chi-square Method (DCM), suggests that planetary movements, especially those of Earth, Jupiter, and Mercury, play a key role in driving the sunspot cycle. His theory focuses on Flux Transfer Events (FTEs), where the magnetic fields of these planets interact with the Sun’s magnetic field. These interactions could create the sunspots and explain other solar phenomena like the Sun’s magnetic polarity reversing every 11 years. The Sun, our closest star, has been a subject of scient...